Mode
Text Size
Log in / Sign up
N/A Completed N=410

Real-life Data From Diabetic Patients on Closed-loop Pumps

Source: ClinicalTrials.gov NCT05418699 ↗
Enrolled (actual)
410
Serious AEs
6.3%
Results posted
Mar 2026
Primary outcomePrimary: HbA1c Level — 6.9 percentage of HBA1c

Summary

To evaluate, in real life, the effect of closed-loop devices on the improvement of glycemic control in diabetic patients managed in the endocrinology departments of secondary care hospitals.

Outcome Measures

OutcomeResultp-value
PRIMARY
HbA1c Level
7.1
SECONDARY
HbA1c Level
7.1
SECONDARY
HbA1c Level
7.1
SECONDARY
Time in Range
73
SECONDARY
Time in Range
73
SECONDARY
Time in Range
73
SECONDARY
Time Below Range
2
SECONDARY
Time Below Range
2
SECONDARY
Time Below Range
2
SECONDARY
Time Above Range
24
SECONDARY
Time Above Range
24
SECONDARY
Time Above Range
24
SECONDARY
Coefficient of Variation
33
SECONDARY
Coefficient of Variation
33
SECONDARY
Coefficient of Variation
33
SECONDARY
HbA1c Level
7.1
SECONDARY
Time in Range
73
SECONDARY
Time Below Range
2
SECONDARY
Time Above Range
24
SECONDARY
Coefficient of Variation
33

Eligibility Criteria

Inclusion Criteria

  • type I diabetic
  • with a closed-loop insulin pump

Exclusion Criteria

  • under legal protection order
  • patient or legal guardian objecting to the use of the data in the research
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT05418699). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search